Tirzepatide (Zepbound, Mounjaro) is a dual-agonist GLP-1 medication. It works like a GLP-1 agonist, but also targets a hormone called glucose-dependent insulinotropic polypeptide (GIP) to “help break ...

GLP-1 users are posting about side effects and symptoms not seen in clinical trials, including irregular periods, fatigue, chills, and hot flashes. Here’s what that may mean for patients.

GLP-1 therapies continue to reshape chronic disease treatment, triggering regulatory updates, new clinical findings and intensifying competition across the pharmaceutical market. On Jan. 13, the FDA ...

In a new trial, people who switched to the experimental daily GLP-1 pill orforglipron were able to keep off most of the weight they had lost taking Wegovy or Zepbound. People who switched from Wegovy ...

GLP-1s are driving demand for smaller portions, due to reducing consumer appetites. Could this lead to smaller pack sizes? And if so, will companies be able to save money from reducing the size of ...

The health of state employees and MassHealth members “is on the line,” clinicians and patients warned on Tuesday, due to diminishing coverage for GLP-1 drugs for weight loss. The cries come against a ...

As GLP‑1 drugs transform consumer diets in real time, food companies are racing to build products that nourish, satisfy and ...

GLP-1 medications have reached a level of household penetration that food and beverage brands can no longer ignore, but the impact on grocery sales is unfolding more gradually than some might expect.

Evidence is mounting that the wildly popular weight-loss medicines known as GLP-1s may also hold potential for treating addiction, and the field may be on the verge of obtaining desperately needed ...

INDIANAPOLIS — It’s just days before Christmas as medical workers wheel 7-year-old Jessa Milender through the halls of the hospital. The normally bubbly child is limp, face-down on a medical gurney.

The growth potential in the GLP-1 market could help healthcare stocks soar in value. Competition, however, is likely to be fierce. Many drugs offer comparable weight loss. Healthcare companies have ...